Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Mar
23
2021
Recreational Use of Cannabis in Mexico: Draft Decree Issued for the Federal Law Regulating Cannabis, Amending the General Health Law and Federal Criminal Code Provisions Greenberg Traurig, LLP
Mar
23
2021
What’s In A Name? How Should Cell-Based Seafood Be Labeled? Womble Bond Dickinson (US) LLP
Mar
23
2021
A Dose of Relief: Federal Judge Dismisses Walgreens Infant Acetaminophen Class Action Proskauer Rose LLP
Mar
23
2021
FDA Issues Warning Letters to Companies Selling CBD Products for Pain Relief Keller and Heckman LLP
Mar
22
2021
The SAFE Banking and CLAIM Acts Will Transform the Cannabis Insurance Industry – Here’s What to Expect Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
22
2021
Lawsuit Filed Over Net Weight and Caloric Content Keller and Heckman LLP
Mar
19
2021
CDC Issues Guidance for Employer-Operated Vaccination Sites McDermott Will & Emery
Mar
19
2021
COVID-19: US State Policy Report – March 17-18, 2021 Squire Patton Boggs (US) LLP
Mar
19
2021
Proposed Settlement in Mowi Smoked Salmon Class Action Keller and Heckman LLP
Mar
19
2021
340B Drug Pricing Program 2021 Outlook [PODCAST] K&L Gates
Mar
19
2021
The Lactalis case: continuation and end Keller and Heckman LLP
Mar
18
2021
You Get a Shot, and You Get a Shot! California Paves the Way for Mandatory Vaccination Policies Proskauer Rose LLP
Mar
18
2021
FDA Issues Import Alert for Higenamine Supplements Keller and Heckman LLP
Mar
18
2021
Can Hashtags Get you in Trouble? Womble Bond Dickinson (US) LLP
Mar
17
2021
Brews, Booze, and Data Breaches Ward and Smith, P.A.
Mar
17
2021
FDA Releases 2019 Food Safety and Nutrition Survey Results Keller and Heckman LLP
Mar
17
2021
EFSA Begins Public Consultation on Draft Updated Guidance on Assessing the Exposure of Operators, Workers, Residents, and Bystanders in Risk Assessment for Plant Protection Products Bergeson & Campbell, P.C.
Mar
16
2021
Pharmaceutical Mergers: U.S. Antitrust Agencies Join Global Working Group Cadwalader, Wickersham & Taft LLP
Mar
15
2021
New Proposed Settlement in Kellogg Class Action Keller and Heckman LLP
Mar
15
2021
CAFC Tightens Enablement Standard for Functional Claiming of Antibodies Proskauer Rose LLP
Mar
12
2021
Comments Summary: Labeling Cell-Cultured Seafood Keller and Heckman LLP
Mar
11
2021
DFEH Issues Guidance to Employers Regarding Mandatory COVID-19 Vaccination Policies Sheppard, Mullin, Richter & Hampton LLP
Mar
11
2021
Delaware Supreme Court Doles Out Landmark Choice-of-Law Decision in Dole Food Case Hunton Andrews Kurth
Mar
11
2021
France Recommends OELs for Titanium Dioxide Nanoparticles Bergeson & Campbell, P.C.
Mar
11
2021
Webinar Recording: Incubating and Launching New Life Science Companies Mintz
Mar
11
2021
Marijuana Legalization Update: Early 2021 Legislative Developments Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Mar
11
2021
Computer Science Meets Medicine in Drug Discovery Womble Bond Dickinson (US) LLP
Mar
10
2021
CDC Releases Initial Guidance: Fully Vaccinated People Can Visit Others, May Not Have to Quarantine After COVID-19 Exposure McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins